DAVENPORT & Co LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$72,000
-76.7%
12,200
+31.1%
0.00%
-50.0%
Q3 2021$309,000
-14.2%
9,3050.0%0.00%
-33.3%
Q2 2021$360,000
-19.6%
9,305
+0.2%
0.00%
-25.0%
Q1 2021$448,000
-7.2%
9,2850.0%0.00%
-20.0%
Q4 2020$483,000
+107.3%
9,285
+6.7%
0.01%
+66.7%
Q3 2020$233,000
+12.0%
8,700
-18.7%
0.00%0.0%
Q2 2020$208,00010,7000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders